Artiva Biotherapeutics Inc. (ARTV) Stock Price, Quote & News - Mboum

Company Profile

Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. The company's lead product candidate includes AlloNK, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody -associa...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 267 4467

Website: www.artivabio.com

Address:

5505 Morehouse Drive, Suite 100, San Diego, United States

night_morning Sep. 10 at 4:49 PM

$ARTV garbage manipulator is holding the stock down

0 · Reply

NVDAMillionaire Sep. 10 at 6:26 AM

$ARTV Great piece that accurately captures ARTV's current position. So if you want to refresh your understanding of ARTV or learn about ARTV for the first time, this is essential reading. https://beyondspx.com/quote/ARTV/analysis/artiva-biotherapeutics-unlocking-the-allogeneic-nk-cell-frontier-in-autoimmunity-nasdaq-artv

0 · Reply

stoneblood Sep. 4 at 6:05 PM

$ARTV trading below cash w/ a ~17month runway looks good here around $3

0 · Reply

dbr_island Aug. 27 at 7:42 PM

$ARTV there it goes NHOD PZG is my next BIG load 🚨🚨🚨 WATCH AND LEARN LIKE👇

0 · Reply

ZoneMonitor Aug. 23 at 6:01 AM

$ARTV Artivion Inc is a medical device company focused on aortic repair with steady growth

0 · Reply

kshonstocks Aug. 18 at 6:12 PM

$ARTV cash 5. 83/share https://finance.yahoo.com/quote/ARTV/key-statistics/

0 · Reply

kshonstocks Aug. 18 at 5:32 PM

$ARTV alert key chart area b/o at 150 dma

0 · Reply

d_risk Aug. 7 at 1:13 AM

$ARTV - Artiva Biotherapeutics Inc. Common Stock - 10Q - Updated Risk Factors ARTV’s 10-Q risk update shows broader autoimmune targets for AlloNK, halted B-NHL follow-up, increased financial losses, new regulatory and supply chain risks, expanded IP and commercialization challenges, plus heightened compliance, data security, and disaster vulnerability concerns. #Biotechnology #SupplyChain #RegulatoryCompliance #FinancialRisk #AutoimmuneDisease 🟢 Added 🟠 Removed https://d-risk.ai/ARTV/10-Q/2025-08-06

0 · Reply

ProfitMaker4 Jul. 24 at 4:32 PM

$ARTV Started buying 06/09 and will be buying shares sub $3 until I hit my upper risk limits. $6.93 BV(PS). Recent drop due to delays in PHASE I (AB-101) Trial overblown. Multiple catalyst 1H-2026 along with numerous additional readouts in 2027-2029. PT: $11.50

0 · Reply

Mollita1313 Jul. 24 at 2:26 PM

$ARTV Any news on this??? Crazy that is up 11% already today with low volume

3 · Reply

Latest News on ARTV

Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025

Aug 25, 2025, 4:05 PM EDT - 18 days ago

Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025

Artiva Biotherapeutics Reports Second Quarter 2025 Financial Results, Recent Business Highlights

Aug 6, 2025, 4:05 PM EDT - 5 weeks ago

Artiva Biotherapeutics Reports Second Quarter 2025 Financial Results, Recent Business Highlights

Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference

May 28, 2025, 4:05 PM EDT - 3 months ago

Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference

Artiva Biotherapeutics Announces Longer-term Phase 1/2 Data Demonstrating Prolonged Durability for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting

May 13, 2025, 4:05 PM EDT - 4 months ago

Artiva Biotherapeutics Announces Longer-term Phase 1/2 Data Demonstrating Prolonged Durability for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting

Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights

May 8, 2025, 8:00 AM EDT - 4 months ago

Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights

Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting

Apr 28, 2025, 4:35 PM EDT - 4 months ago

Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting

Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer

Apr 8, 2025, 4:05 PM EDT - 5 months ago

Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer

Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Mar 31, 2025, 4:05 PM EDT - 5 months ago

Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights

Mar 24, 2025, 4:05 PM EDT - 6 months ago

Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights

Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 20, 2025, 4:05 PM EST - 7 months ago

Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference

Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.

Jan 29, 2025, 4:05 PM EST - 8 months ago

Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.

Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Nov 12, 2024, 4:05 PM EST - 10 months ago

Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference

Nov 11, 2024, 4:05 PM EST - 10 months ago

Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference

Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors

Oct 22, 2024, 4:05 PM EDT - 11 months ago

Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors

Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 10, 2024, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference

Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aug 29, 2024, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch

Aug 13, 2024, 2:14 PM EDT - 1 year ago

Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch

Artiva: Natural Killer Cell Biotech With 1st Half Of 2025 Lupus Treatment Data

Jul 22, 2024, 3:55 PM EDT - 1 year ago

Artiva: Natural Killer Cell Biotech With 1st Half Of 2025 Lupus Treatment Data

U.S. IPO Weekly Recap: Insurance And Healthcare Lead A 4 IPO Week

Jul 20, 2024, 4:50 AM EDT - 1 year ago

U.S. IPO Weekly Recap: Insurance And Healthcare Lead A 4 IPO Week

ACTU ARDT BLMZ CON LINE OS QMMM

Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering

Jul 18, 2024, 7:08 PM EDT - 1 year ago

Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering

night_morning Sep. 10 at 4:49 PM

$ARTV garbage manipulator is holding the stock down

0 · Reply

NVDAMillionaire Sep. 10 at 6:26 AM

$ARTV Great piece that accurately captures ARTV's current position. So if you want to refresh your understanding of ARTV or learn about ARTV for the first time, this is essential reading. https://beyondspx.com/quote/ARTV/analysis/artiva-biotherapeutics-unlocking-the-allogeneic-nk-cell-frontier-in-autoimmunity-nasdaq-artv

0 · Reply

stoneblood Sep. 4 at 6:05 PM

$ARTV trading below cash w/ a ~17month runway looks good here around $3

0 · Reply

dbr_island Aug. 27 at 7:42 PM

$ARTV there it goes NHOD PZG is my next BIG load 🚨🚨🚨 WATCH AND LEARN LIKE👇

0 · Reply

ZoneMonitor Aug. 23 at 6:01 AM

$ARTV Artivion Inc is a medical device company focused on aortic repair with steady growth

0 · Reply

kshonstocks Aug. 18 at 6:12 PM

$ARTV cash 5. 83/share https://finance.yahoo.com/quote/ARTV/key-statistics/

0 · Reply

kshonstocks Aug. 18 at 5:32 PM

$ARTV alert key chart area b/o at 150 dma

0 · Reply

d_risk Aug. 7 at 1:13 AM

$ARTV - Artiva Biotherapeutics Inc. Common Stock - 10Q - Updated Risk Factors ARTV’s 10-Q risk update shows broader autoimmune targets for AlloNK, halted B-NHL follow-up, increased financial losses, new regulatory and supply chain risks, expanded IP and commercialization challenges, plus heightened compliance, data security, and disaster vulnerability concerns. #Biotechnology #SupplyChain #RegulatoryCompliance #FinancialRisk #AutoimmuneDisease 🟢 Added 🟠 Removed https://d-risk.ai/ARTV/10-Q/2025-08-06

0 · Reply

ProfitMaker4 Jul. 24 at 4:32 PM

$ARTV Started buying 06/09 and will be buying shares sub $3 until I hit my upper risk limits. $6.93 BV(PS). Recent drop due to delays in PHASE I (AB-101) Trial overblown. Multiple catalyst 1H-2026 along with numerous additional readouts in 2027-2029. PT: $11.50

0 · Reply

Mollita1313 Jul. 24 at 2:26 PM

$ARTV Any news on this??? Crazy that is up 11% already today with low volume

3 · Reply

Supplement Jul. 24 at 1:27 PM

$ARTV With all this upward momentum something has to be brewing behind the scenes. Super exciting to see the SP go up everyday.

0 · Reply

Dumb_money_big_gains Jul. 23 at 7:29 PM

$ARTV market cap is higher, but the sentiment remains.

0 · Reply

Dumb_money_big_gains Jul. 23 at 7:27 PM

$ARTV do we have a little squeeze coming on?

0 · Reply

Supplement Jul. 23 at 7:19 PM

$ARTV We really only have one more hurdle and then we fly. We need to kick down the door at 14 Day RSI at 80% 3.33. #bullishAF

0 · Reply

Supplement Jul. 23 at 7:05 PM

$ARTV here we go.. possible next stop like $3.33 - $5

0 · Reply

Swift_Trades Jul. 23 at 7:04 PM

$ARTV lesss go!!!

0 · Reply

Supplement Jul. 23 at 6:51 PM

$ARTV Everybody is sleeping on artiva. $ARTV #bullish 15 bucks incoming.

0 · Reply

kshonstocks Jul. 23 at 5:13 PM

$ARTV nice 100 dma b/o pattern

0 · Reply

Supplement Jul. 21 at 2:05 PM

$ARTV Still no news but I have a feeling it has something to do with $AFMD affimed's insolvency.

1 · Reply

Swift_Trades Jul. 17 at 2:58 PM

$ARTV 🖨️🖨️🖨️

0 · Reply

Dumb_money_big_gains Jul. 16 at 7:24 PM

$ARTV weird price action lately.

1 · Reply

ThebookofEli Jul. 15 at 6:59 PM

$ARTV watching

0 · Reply